| Dr Arnold Bulos, OD | |
|
856 Briarwood Cir, Briarwood Mall, Ann Arbor, MI 48108-1616 | |
| (734) 761-8300 | |
| (734) 769-1018 |
| Full Name | Dr Arnold Bulos |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 856 Briarwood Cir, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164590303 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901003799 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arnold Bulos, OD 3916 Steamboat Ct, Ann Arbor, MI 48108-9324 Ph: (734) 769-5777 | Dr Arnold Bulos, OD 856 Briarwood Cir, Briarwood Mall, Ann Arbor, MI 48108-1616 Ph: (734) 761-8300 |
News Archive
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumors, opening the way for potential new drugs to be developed.
Traffic-related air pollution, known to raise the risk for cardiovascular disease, may also increase the risk of developing type 2 diabetes in women. Low-grade inflammation may contribute to the higher incidence of type 2 diabetes in women exposed to air pollution, according to German researchers.
In a post on IntraHealth's "Global Health Blog," Rebecca Kohler, senior vice president of corporate strategy and development at IntraHealth, writes about an event held last week on the sidelines of the Democratic National Convention (DNC) that "focused on the vital role of women's health in foreign policy."
Idera Pharmaceuticals, Inc. announced today preliminary data from a 4-week dose-ranging Phase 1 clinical trial of IMO-2125 in combination with ribavirin in 60 treatment-naïve patients with genotype 1 chronic hepatitis C virus (HCV) infection. In the trial, treatment with IMO-2125 in combination with ribavirin was well tolerated and achieved substantial decline in virus levels at two days after the first dose of IMO-2125 and after four weeks of treatment.
Scientists have helped provide a way to better understand how to enable drugs to enter the brain and how cancer cells make it past the blood brain barrier. The brain is protected by the near-impermeable blood brain barrier, a fortress which protects the brain but which also prevents the treatment of brain diseases, including brain tumors.
› Verified 8 days ago
Bennett Optometry Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1928 W Stadium Blvd, Ann Arbor, MI 48103 Phone: 734-994-9119 | |
Sherry H Day, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1000 Wall St, Ann Arbor, MI 48105 Phone: 734-764-4190 | |
Dr. Jaclyn Marie Mckenzie, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3601 Washtenaw Ave, Ann Arbor, MI 48104 Phone: 734-973-1712 Fax: 734-973-1712 | |
Mia Hill, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 117 S Main St, Ann Arbor, MI 48104 Phone: 734-665-5306 Fax: 734-665-5522 | |
Audree Shanae Bass, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Bennett Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 2000 Green Rd, Suite 200, Ann Arbor, MI 48105 Phone: 636-200-4393 Fax: 734-930-2390 | |
Dr. Monika Dembinska, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5159 Plymouth, Ann Arbor, MI 48105 Phone: 734-492-3858 |